INTRODUCTION
Adenomatous polyps are the commonest neoplasms found during colorectal cancer screening [1] . Detection and removal of these cancer precursors may prevent many cancers and reduce mortality [2] . However, a proportion of neoplastic polyps are incompletely resected [3] , resulting in local recurrence, especially after resection of large polyps (≥ 20 mm), in 4.3% to 36.7% of cases [4] [5] [6] [7] [8] [9] [10] . Not only size [4, 6, [8] [9] [10] , but also piecemeal resection [7, [9] [10] [11] , histology of adenoma (compared with serrated polyp) [5, 10] , and intraprocedural bleeding [6, 10] are also reportedly risk factors for local recurrence. A systematic review found that local recurrence after endoscopic mucosal resection (EMR) of non-pedunculated colorectal lesions occurs in 3% of en bloc resections and 20% of piecemeal resections; more than 90% of recurrences are detected 6 mo after EMR [12] . Periodic inspection by colonoscopy is desirable for early detection of local residual tumors/recurrences, and endoscopic management measures being suitable for many such lesions that are detected early [13] . The European Society of Gastrointestinal Endoscopy guideline recommends endoscopic follow-up within 6 mo of piecemeal resection of adenomas larger than 10 mm [14] . Local recurrences that develop after endoscopic resection of intramucosal neoplasms that lacked risk factors for lymph node metastasis or positive vertical margins are usually treated endoscopically. Here we review and summarize the management of local recurrence after endoscopic resection.
MANAGEMENT OF LOCAL RECURRENCE AFTER ENDOSCOPIC RESECTION
Several groups have reported their management of local recurrences. Hotta et al [11] reported performing additional endoscopic resection in 32 of 34 recurrent lesions (94%), the remaining two patients (6%) undergoing additional surgery. In a multicenter prospective study of 1000 consecutive wide-field EMRs, 93% (135 of 145) of local recurrences were successfully resected endoscopically, the remaining 10 being referred for surgery [6] . Knabe et al [7] reported a prospective two-center study of 243 consecutive patients with 252 adenomas resected endoscopically. Seventy-seven residual tumors and recurrences were all treated by endoscopic resection and/or argon plasma coagulation. Sakamoto et al [15] have reported a retrospective study of 60 consecutive patients with locally recurrent or residual tumors after endoscopic resection. Of 69 lesions in 60 patients, 67 were treated endoscopically, whereas two required surgical treatment. En bloc resection rates were 39% (23/58) with EMR (39%) and 56% (5/9) with endoscopic submucosal dissection (ESD) [15] . According to the Japan Gastroenterological Endoscopy Society guidelines for colorectal ESD/EMR [13] , ESD ( Figure 1 ) is indicated for local residual or recurrent early carcinomas after endoscopic resection. Although most local recurrences can be treated endoscopically, additional endoscopic resection is technically challenging because of severe fibrosis at the original resection site because such fibrosis results in the nonlifting sign with submucosal fluid injection. Thus, ESD for such recurrences is technically difficult and typically a lengthy procedure.
Underwater EMR (UEMR) was developed and described by Binmoeller et al [16] in 2012. In this procedure, air is evacuated from the affected segment of lumen and water infused until the lumen is complete full, at which stage hot snare polypectomy is performed without submucosal injection. This procedure is reportedly effective for resecting large polyps [16, 17] . It is also suitable for recurrent or residual lesions. Kim et al [18] reported a retrospective, cross-sectional study of patients with recurrent adenoma after piecemeal EMR of colorectal laterally spreading tumor (≥ 2 cm). The en bloc resection rate (47% vs 16%, P = 0.002) and complete resection rate (89% vs 32%, P < 0.001) were significantly higher in the UEMR group (n = 36) than that of the conventional EMR (n = 44) [18] . Argon plasma coagulation of visible residual lesions during the salvage procedure was less frequently required in the UEMR than the EMR group (11% vs 66%, P < 0.001). The recurrence rate at follow-up colonoscopy was significantly lower in the UEMR group (10% vs 39%, P = 0.02). In this trial, UEMR was an independent predictor of en bloc resection and complete resection, whereas a large recurrent lesion is a negative independent predictor of successful en bloc resection and complete endoscopic removal. We therefore perform UEMR for relatively small (≤ 10-15 mm) recurrent lesions ( Figure 2 ) and ESD for larger lesions.
Even with the technical advances of ESD and development of UEMR, endoscopic treatment of recurrent lesions is still challenging. We therefore recommend precise diagnosis of the extent of naïve lesions by careful examination using indigo carmine and/or narrow band imaging endoscopy. We also recommend close follow-up after The Japan Narrow-band imaging Expert Team classification was type 2B [19] ; C: Kudo's pit pattern was V I [20] . The laterally spreading tumor was diagnosed as an intramucosal lesion and ESD performed; D, E: Although there was severe fibrosis in the submucosal layer, en bloc resection was achieved; F: The pathological diagnosis was adenocarcinoma arising from a sessile serrated adenoma/polyp, type 0-IIa, 16 × 15 mm, pTis, pHM0, pVM0; ER0, Cur EA; pap > tub1, ly0, v0.
piecemeal resection or resection of large polyps. 
